HLA-B locus in Caucasian patients with carbamazepine hypersensitivity

Author： Alfirevic Ana Jorgensen Andrea L Williamson Paula R Chadwick David W Park B Kevin Pirmohamed Munir

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.7, Iss.6, 2006-09, pp. : 813-818

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Increased carbamazepine-related SJS/TEN risk with HLA-B*1502

Reactions Weekly, Vol. 1, Iss. 1183, 2008-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Carbamazepine, HLA-B*1502 and risk of Stevens––Johnson syndrome and toxic epidermal necrolysis: US FDA recommendations

By Ferrell P Brent McLeod Howard L

Pharmacogenomics, Vol. 9, Iss. 10, 2008-10 ,pp. : 1543-1546

Future Medicine

Access to resources Recommend Favorite

External quality assessment for laboratory testing of HLA‐B*15:02 allele in relation to carbamazepine therapy

Journal Of Clinical Laboratory Analysis (Electronic), Vol. 32, Iss. 2, 2018-02 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Phenytoin safety questioned for HLA-B*1502-positive patients

Inpharma, Vol. 1, Iss. 1666, 2008-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

Association of the genetic marker for abacavir hypersensitivity HLA-B*5701 with HCP5 rs2395029 in Mexican Mestizos

By Sanchez-Giron Francisco Villegas-Torres Beatriz Jaramillo-Villafuerte Karla Silva-Zolezzi Irma Fernandez-Lopez Juan Carlos Jimenez-Sanchez Gerardo Carnevale Alessandra

Pharmacogenomics, Vol. 12, Iss. 6, 2011-06 ,pp. : 809-814

Future Medicine

Access to resources Recommend Favorite